| Product Code: ETC6748524 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Neuropathic Pain Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Neuropathic Pain Market Revenues & Volume, 2021 & 2031F |
3.3 China Neuropathic Pain Market - Industry Life Cycle |
3.4 China Neuropathic Pain Market - Porter's Five Forces |
3.5 China Neuropathic Pain Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 China Neuropathic Pain Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 China Neuropathic Pain Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 China Neuropathic Pain Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.10 China Neuropathic Pain Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.11 China Neuropathic Pain Market Revenues & Volume Share, By Pain Type, 2021 & 2031F |
4 China Neuropathic Pain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of neuropathic pain in China |
4.2.2 Increasing awareness and diagnosis of neuropathic pain in the country |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in China |
4.3 Market Restraints |
4.3.1 High cost of neuropathic pain treatment and medications |
4.3.2 Limited availability of specialized healthcare professionals for neuropathic pain management in China |
4.3.3 Stringent regulatory requirements for approval of neuropathic pain therapies in the market |
5 China Neuropathic Pain Market Trends |
6 China Neuropathic Pain Market, By Types |
6.1 China Neuropathic Pain Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Neuropathic Pain Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Neuropathic Pain Market Revenues & Volume, By Spinal Cord Stimulation (SCS) Devices, 2021- 2031F |
6.1.4 China Neuropathic Pain Market Revenues & Volume, By External Peripheral Nerve Stimulation, 2021- 2031F |
6.1.5 China Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (Tens) Devices, 2021- 2031F |
6.2 China Neuropathic Pain Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 China Neuropathic Pain Market Revenues & Volume, By Rechargeable and Non-Rechargeable, 2021- 2031F |
6.3 China Neuropathic Pain Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 China Neuropathic Pain Market Revenues & Volume, By Invasive and Non-Invasive, 2021- 2031F |
6.4 China Neuropathic Pain Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 China Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation, 2021- 2031F |
6.4.3 China Neuropathic Pain Market Revenues & Volume, By Transcranial Magnetic Stimulation, 2021- 2031F |
6.4.4 China Neuropathic Pain Market Revenues & Volume, By Respiratory Electrical Stimulation, 2021- 2031F |
6.5 China Neuropathic Pain Market, By Modality |
6.5.1 Overview and Analysis |
6.5.2 China Neuropathic Pain Market Revenues & Volume, By Stationary, 2021- 2031F |
6.5.3 China Neuropathic Pain Market Revenues & Volume, By Portable, 2021- 2031F |
6.6 China Neuropathic Pain Market, By Mode of Purchase |
6.6.1 Overview and Analysis |
6.6.2 China Neuropathic Pain Market Revenues & Volume, By Over-the-Counter Devices, 2021- 2031F |
6.6.3 China Neuropathic Pain Market Revenues & Volume, By Prescription-Based Devices, 2021- 2031F |
6.7 China Neuropathic Pain Market, By Pain Type |
6.7.1 Overview and Analysis |
6.7.2 China Neuropathic Pain Market Revenues & Volume, By Peripheral Neuropathy, 2021- 2031F |
6.7.3 China Neuropathic Pain Market Revenues & Volume, By Entrapment Neuropathy, 2021- 2031F |
6.7.4 China Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.5 China Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.6 China Neuropathic Pain Market Revenues & Volume, By Post Herpetic Neuralgia (PHN), 2021- 2031F |
6.7.7 China Neuropathic Pain Market Revenues & Volume, By Post Traumatic Neuropathy, 2021- 2031F |
6.7.8 China Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.7.9 China Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.8 China Neuropathic Pain Market, By Indication |
6.8.1 Overview and Analysis |
6.8.2 China Neuropathic Pain Market Revenues & Volume, By Spinal Stenosis, 2021- 2031F |
6.8.3 China Neuropathic Pain Market Revenues & Volume, By Chemotherapy-Induced Peripheral Neuropathy, 2021- 2031F |
6.8.4 China Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
6.8.5 China Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
7 China Neuropathic Pain Market Import-Export Trade Statistics |
7.1 China Neuropathic Pain Market Export to Major Countries |
7.2 China Neuropathic Pain Market Imports from Major Countries |
8 China Neuropathic Pain Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis for neuropathic pain patients in China |
8.2 Percentage increase in the number of healthcare facilities offering neuropathic pain treatments |
8.3 Adoption rate of non-pharmacological interventions for neuropathic pain management in China |
9 China Neuropathic Pain Market - Opportunity Assessment |
9.1 China Neuropathic Pain Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Neuropathic Pain Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 China Neuropathic Pain Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 China Neuropathic Pain Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 China Neuropathic Pain Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.6 China Neuropathic Pain Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
9.7 China Neuropathic Pain Market Opportunity Assessment, By Pain Type, 2021 & 2031F |
9.7 China Neuropathic Pain Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 China Neuropathic Pain Market - Competitive Landscape |
10.1 China Neuropathic Pain Market Revenue Share, By Companies, 2024 |
10.2 China Neuropathic Pain Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here